CASI Pharmaceuticals, Inc (DE) Annual Costs and Expenses in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
CASI Pharmaceuticals, Inc (DE) quarterly/annual Costs and Expenses history and growth rate from 2010 to 2022.
  • CASI Pharmaceuticals, Inc (DE) Costs and Expenses for the quarter ending December 31, 2022 was $23.6M, a 44% increase year-over-year.
  • CASI Pharmaceuticals, Inc (DE) Costs and Expenses for the twelve months ending December 31, 2022 was $61.3M, a 3.7% increase year-over-year.
  • CASI Pharmaceuticals, Inc (DE) annual Costs and Expenses for 2022 was $61.3M, a 3.7% increase from 2021.
  • CASI Pharmaceuticals, Inc (DE) annual Costs and Expenses for 2021 was $59.1M, a 1.22% increase from 2020.
  • CASI Pharmaceuticals, Inc (DE) annual Costs and Expenses for 2020 was $58.4M, a 14.3% increase from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $61.3M +$2.19M +3.7% Jan 1, 2022 Dec 31, 2022 20-F 2023-04-26
2021 $59.1M +$713K +1.22% Jan 1, 2021 Dec 31, 2021 20-F 2023-04-26
2020 $58.4M +$7.33M +14.3% Jan 1, 2020 Dec 31, 2020 20-F 2023-04-26
2019 $51.1M +$23.9M +87.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 $27.2M +$16.4M +153% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $10.8M +$1.33M +14.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $9.42M +$2.22M +30.8% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-29
2015 $7.2M -$19M -72.5% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 $26.2M +$20.5M +357% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-28
2013 $5.74M +$567K +11% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-27
2012 $5.17M -$1.34M -20.5% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-21
2011 $6.51M -$4.72M -42% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-21
2010 $11.2M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.